P

Inventor

ROEMER MICHAEL

DE57 patents
⚠️ This page may combine multiple inventors who share the name “ROEMER MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK PATENT GMBH

27 patents
US4639328AJan 27, 1987

Thienothiophene derivatives

MERCK PATENT GMBH77 citations96
US4551264ANov 5, 1985

Polyhalogenoaromatic compounds for liquid crystal compositions

MERCK PATENT GMBH83 citations96
US4510069AApr 9, 1985

Cyclohexane derivatives

MERCK PATENT GMBH84 citations96
US4400293AAug 23, 1983

Liquid crystalline cyclohexylphenyl derivatives

MERCK PATENT GMBH76 citations96
US4606845AAug 19, 1986

Bicyclohexylethanes

MERCK PATENT GMBH41 citations93
US4490305ADec 25, 1984

Liquid-crystalline halogen compounds, process for their preparation, dielectrics containing these, and electro-optical display element

MERCK PATENT GMBH30 citations93
US4419264ADec 6, 1983

Fluorine-containing 4,4'-bis-(cyclohexyl)-biphenyl derivatives, and dielectrics and electro-optical display elements containing them

MERCK PATENT GMBH28 citations93
US4386007AMay 31, 1983

Liquid crystalline naphthalene derivatives

MERCK PATENT GMBH35 citations93
US4776973AOct 11, 1988

Pyrimidine derivatives

MERCK PATENT GMBH34 citations92
US4730904AMar 15, 1988

Organosilicon compounds

MERCK PATENT GMBH35 citations92
US4331552AMay 25, 1982

Liquid crystalline, partially hydrogenated oligo-1,4-phenylenes and dielectrics and electro-optical display elements containing them

MERCK PATENT GMBH43 citations92
US4699636AOct 13, 1987

Process for outgassing liquid-crystalline materials

MERCK PATENT GMBH33 citations91
US4724097AFeb 9, 1988

Bicyclohexylethanes

MERCK PATENT GMBH27 citations90
US5308538AMay 3, 1994

Supertwist liquid-crystal display

MERCK PATENT GMBH24 citations89
US5108652AApr 28, 1992

Cyclohexane derivatives

MERCK PATENT GMBH20 citations82
US4622164ANov 11, 1986

Bicyclohexyls

MERCK PATENT GMBH17 citations82
US4620938ANov 4, 1986

Hydroterphenyls

MERCK PATENT GMBH25 citations82
US4505837AMar 19, 1985

Liquid crystalline phenylcyclohexene derivatives

MERCK PATENT GMBH26 citations82
US4986931AJan 22, 1991

Cyclohexane derivatives

MERCK PATENT GMBH7 citations74
US4868341ASep 19, 1989

Bicyclohexyls

MERCK PATENT GMBH8 citations74
US4812258AMar 14, 1989

Fluorine-containing pyrimidine derivatives

MERCK PATENT GMBH15 citations74
US4505838AMar 19, 1985

Halogenobiphenyl derivatives

MERCK PATENT GMBH12 citations74
US4473487ASep 25, 1984

4-Fluorobiphenyl derivatives, their preparation, and dielectrics and electro-optical display element containing them

MERCK PATENT GMBH14 citations74
US4740624AApr 26, 1988

Process for the preparation of ketones

MERCK PATENT GMBH14 citations73
US5023379AJun 11, 1991

Process for the preparation of hydroxyamines

MERCK PATENT GMBH16 citations71
US4544771AOct 1, 1985

Halogenobiphenyl derivatives

MERCK PATENT GMBH3 citations63
US4354976AOct 19, 1982

Process for the preparation of azidobenzal compounds

MERCK PATENT GMBH2 citations63

IMMATICS BIOTECHNOLOGIES GMBH

17 patents
US11732021B2Aug 22, 2023

Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods

IMMATICS BIOTECHNOLOGIES GMBH3 citations84
US11655281B2May 23, 2023

Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods

IMMATICS BIOTECHNOLOGIES GMBH3 citations84
US11655280B2May 23, 2023

Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods

IMMATICS BIOTECHNOLOGIES GMBH2 citations73
US11603397B2Mar 14, 2023

Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods

IMMATICS BIOTECHNOLOGIES GMBH2 citations73
US12318407B2Jun 3, 2025

Peptides displayed by HLA for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12290530B2May 6, 2025

Peptides displayed by HLA for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12285443B2Apr 29, 2025

Peptides displayed by HLA for use immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12274716B2Apr 15, 2025

Peptides displayed by HLA for use immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12257269B2Mar 25, 2025

Peptides displayed by HLA for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12246039B2Mar 11, 2025

Peptides displayed by HLA for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12227556B2Feb 18, 2025

Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12202878B2Jan 21, 2025

Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12195516B2Jan 14, 2025

Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12084486B2Sep 10, 2024

Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11957716B2Apr 16, 2024

Peptides displayed by HLA for use in immunotherapy against different types of cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11779605B2Oct 10, 2023

Immunotherapy with b*08 restricted peptides and combination of peptides against cancers and related methods

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11433099B2Sep 6, 2022

Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods

IMMATICS BIOTECHNOLOGIES GMBH0 citations62

SECR DEFENCE BRIT

2 patents

SCHERING AG

2 patents

HOECHST AG

1 patent

MANNESMANN VDO AG

1 patent

Showing the top 50 of 57 patents by PatentIndex Score.